TARPLIN, DOWNS & YOUNG, LLC

Lobbying for ELI LILLY AND COMPANY · Pharmaceutical company focused on innovation to improve global health

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Indiana · House · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 3

Health Issues

IRA, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, drug pricing in federal programs

Medicare/Medicaid

Medicare & Medicaid payment and coverage issues, Medicare Part D, Medicare Part B, drug pricing in federal programs

Budget/Appropriations

federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.